BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10050049)

  • 1. Regulation of the activities of thrombin and plasmin by cholesterol sulfate as a physiological inhibitor in human plasma.
    Iwamori M; Iwamori Y; Ito N
    J Biochem; 1999 Mar; 125(3):594-601. PubMed ID: 10050049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of pancreatic elastase by sulfated lipids in the intestinal mucosa.
    Ito N; Iwamori Y; Hanaoka K; Iwamori M
    J Biochem; 1998 Jan; 123(1):107-14. PubMed ID: 9504416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of proteases involved in embryo implantation by cholesterol sulfate.
    Koizumi M; Momoeda M; Hiroi H; Nakazawa F; Nakae H; Ohno T; Yano T; Taketani Y
    Hum Reprod; 2010 Jan; 25(1):192-7. PubMed ID: 19897854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shedding of sulfated lipids into gastric fluid and inhibition of pancreatic DNase I by cholesterol sulfate in concert with bile acids.
    Iwamori M; Suzuki H; Kimura T; Iwamori Y
    Biochim Biophys Acta; 2000 Sep; 1487(2-3):268-74. PubMed ID: 11018478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfated, low-molecular-weight lignins are potent inhibitorsof plasmin, in addition to thrombin and factor Xa: Novel opportunity for controlling complex pathologies.
    Henry BL; Abdel Aziz M; Zhou Q; Desai UR
    Thromb Haemost; 2010 Mar; 103(3):507-15. PubMed ID: 20024500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation of thrombin- and plasmin-mediated activation of thrombin-activatable fibrinolysis inhibitor by anionic molecules.
    Plug T; Meijers JC
    Thromb Res; 2016 Oct; 146():7-14. PubMed ID: 27564657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombin inhibitors as antithrombotic agents: the importance of rapid inhibition.
    Stone SR; Tapparelli C
    J Enzyme Inhib; 1995; 9(1):3-15. PubMed ID: 8568565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombospondin is a slow tight-binding inhibitor of plasmin.
    Hogg PJ; Stenflo J; Mosher DF
    Biochemistry; 1992 Jan; 31(1):265-9. PubMed ID: 1531022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of S18326 as a new potent and selective boronic acid direct thrombin inhibitor.
    Rupin A; Mennecier P; Lila C; de Nanteuil G; Verbeuren TJ
    Thromb Haemost; 1997 Oct; 78(4):1221-7. PubMed ID: 9364988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors.
    Komorowicz E; Kolev K; Machovich R
    Biochemistry; 1998 Jun; 37(25):9112-8. PubMed ID: 9636057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cabbage seed protease inhibitor: a slow, tight-binding inhibitor of trypsin with activity toward thrombin, activated Stuart factor (factor Xa), activated Hageman factor (factor XIIa), and plasmin.
    Carter TH; Everson BA; Ratnoff OD
    Blood; 1990 Jan; 75(1):108-15. PubMed ID: 2136800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmin regulation through allosteric, sulfated, small molecules.
    Al-Horani RA; Karuturi R; White DT; Desai UR
    Molecules; 2015 Jan; 20(1):608-24. PubMed ID: 25569517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly Potent and Selective Plasmin Inhibitors Based on the Sunflower Trypsin Inhibitor-1 Scaffold Attenuate Fibrinolysis in Plasma.
    Swedberg JE; Wu G; Mahatmanto T; Durek T; Caradoc-Davies TT; Whisstock JC; Law RHP; Craik DJ
    J Med Chem; 2019 Jan; 62(2):552-560. PubMed ID: 30520638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aqueous extract from Brownea grandiceps flowers with effect on coagulation and fibrinolytic system.
    Pereira B; Brazón J
    J Ethnopharmacol; 2015 Feb; 160():6-13. PubMed ID: 25460592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azetidin-2-one derivatives as inhibitors of thrombin.
    Han WT; Trehan AK; Wright JJ; Federici ME; Seiler SM; Meanwell NA
    Bioorg Med Chem; 1995 Aug; 3(8):1123-43. PubMed ID: 7582985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction in human plasma of antiplasmin, the fast-reacting plasmin inhibitor, with plasmin, thrombin, trypsin and chymotrypsin.
    Edy J; Collen D
    Biochim Biophys Acta; 1977 Oct; 484(2):423-32. PubMed ID: 143966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfated lipids as inhibitors of pancreatic trypsin and chymotrypsin in epithelium of the mammalian digestive tract.
    Iwamori M; Iwamori Y; Ito N
    Biochem Biophys Res Commun; 1997 Aug; 237(2):262-5. PubMed ID: 9268697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The reaction between plasmin and C1-inhibitor results in plasmin inhibition by the serpin mechanism.
    Brown EW; Ravindran S; Patston PA
    Blood Coagul Fibrinolysis; 2002 Dec; 13(8):711-4. PubMed ID: 12441910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of tripeptidic plasmin inhibitors with nitrile as warhead.
    Teno N; Otsubo T; Gohda K; Wanaka K; Sueda T; Ikeda K; Hijikata-Okunomiya A; Tsuda Y
    J Pept Sci; 2012 Oct; 18(10):620-5. PubMed ID: 22961872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombin activatable fibrinolysis inhibitor (TAFI) affects fibrinolysis in a plasminogen activator concentration-dependent manner. Study of seven plasminogen activators in an internal clot lysis model.
    Guimarães AH; Rijken DC
    Thromb Haemost; 2004 Mar; 91(3):473-9. PubMed ID: 14983222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.